Procaps Group Sa Stock Fundamentals

PROCWDelisted Stock  USD 0.01  0.00  0.00%   
Procaps Group SA fundamentals help investors to digest information that contributes to Procaps Group's financial success or failures. It also enables traders to predict the movement of Procaps Pink Sheet. The fundamental analysis module provides a way to measure Procaps Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Procaps Group pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Procaps Group SA Company Return On Equity Analysis

Procaps Group's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Procaps Group Return On Equity

    
  0.37  
Most of Procaps Group's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Procaps Group SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Procaps Group SA has a Return On Equity of 0.3737. This is 101.56% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is notably lower than that of the firm.

Procaps Group SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Procaps Group's current stock value. Our valuation model uses many indicators to compare Procaps Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Procaps Group competition to find correlations between indicators driving Procaps Group's intrinsic value. More Info.
JavaScript chart by amCharts 3.21.15PROCQSIAWJSPRWPROCW -0.6-0.5-0.4-0.3-0.2-0.10 -1.2-1.0-0.8-0.6-0.4-0.200.20.4
Procaps Group SA is regarded second in return on equity category among its peers. It also is regarded second in return on asset category among its peers reporting about  0.17  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Procaps Group SA is roughly  5.95 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Procaps Group's earnings, one of the primary drivers of an investment's value.

Procaps Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Procaps Group's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Procaps Group could also be used in its relative valuation, which is a method of valuing Procaps Group by comparing valuation metrics of similar companies.
100%
Procaps Group is currently under evaluation in return on equity category among its peers.

Procaps Fundamentals

About Procaps Group Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Procaps Group SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procaps Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procaps Group SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Procaps Group, S.A. develops, manufactures, and markets over-the-counter and prescription drugs, nutritional supplements, and clinical solutions. The company was founded in 1977 and is based in Luxembourg City, Luxembourg Procaps Group is traded on NASDAQ Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Procaps Pink Sheet

If you are still planning to invest in Procaps Group SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Procaps Group's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stocks Directory
Find actively traded stocks across global markets